EBS
Emergent Biosolutions Inc
NYSE: EBS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$8.23
+3.00% today
Updated 2026-04-30
Market cap
$414.70M
P/E ratio
8.63
P/S ratio
0.56x
EPS (TTM)
$0.93
Dividend yield
—
52W range
$5 – $14
Volume
0.9M
Emergent Biosolutions Inc (EBS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+0.5%
Last 4 quarters
Revenue YoY growth
-23.6%
Most recent quarter
EPS YoY growth
+25.5%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+16.8%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+35.6%
2025-10-29
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-10 | $-0.43 | -201.2% | $8.35 | $8.18 | -2.0% |
| 2025-10-29 | $1.06 | +2169.8% | $9.47 | $12.84 | +35.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.43 | $-0.43 | -201.2% | $148.70M | -23.6% |
| 2025-09-30 | $0.05 | $1.06 | +2169.8% | $231.10M | -21.3% |
| 2025-06-30 | $-0.10 | $0.16 | +260.0% | $140.90M | -44.7% |
| 2025-03-31 | $0.70 | $0.71 | +1.4% | $222.20M | -26.0% |
| 2024-12-31 | $-0.50 | $-0.58 | -16.5% | $194.70M | -29.6% |
| 2024-09-30 | $0.14 | $1.37 | +878.6% | $293.80M | +8.6% |
| 2024-06-30 | $-0.94 | $-2.32 | -146.8% | $254.70M | -24.6% |
| 2024-03-31 | $-0.86 | $0.59 | +168.6% | $300.40M | +82.8% |
| 2023-12-31 | $-0.19 | $-0.77 | -305.3% | $276.60M | — |
| 2023-09-30 | $-0.22 | $-0.54 | -145.5% | $270.50M | — |
| 2023-06-30 | $-0.49 | $-1.06 | -116.3% | $337.90M | — |
| 2023-03-31 | $-1.24 | $-3.17 | -155.6% | $164.30M | — |
| 2022-12-31 | $0.04 | $-0.31 | -875.0% | — | — |
Frequently asked questions
Has Emergent Biosolutions Inc beaten earnings estimates?
Emergent Biosolutions Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +0.5% over the last 3 quarters.
How does EBS stock react to earnings?
EBS stock has moved an average of +16.8% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Emergent Biosolutions Inc's revenue growth rate?
Emergent Biosolutions Inc reported year-over-year revenue growth of -23.6% in its most recent quarter, with EPS growing +25.5% year-over-year.